Johnson & Johnson (JNJ)'s DePuy Aims to Reverse $8.3 Million Metal Hip Implant Loss
4/23/2013 8:29:19 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Johnson & Johnson subsidiary DePuy Orthopaedics asks a California judge to stay an $8.3 million jury decision against the company while attorneys file an appeal. Johnson & Johnson (NYSE:JNJ) and its DePuy Orthopaedics subsidiary are hoping to dodge an $8.3 million judgment stemming from the company's 1st metal-on-metal hip implant complaint to go to trial. DePuy last week asked the Los Angeles Superior Court to put a hold on the jury's decision in a trial brought by patient Loren Kransky, who claimed his ASR hip failed less than 5 years after he received it.
Help employers find you! Check out all the jobs and post your resume.
comments powered by